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ABSTRACT 
"troduction :Following a binding interaction between a foreign glycoprotein molecule 
(antigen) and a receptor molecule on one or more antibodies (immunoglobulins) are the 
major soluble molecules produced to know the pattern of these interactions. The specific and 
avid interaction of antigen with antibody, is central to an effective defensive role for the 
-.libody response. After knowing each antibody effect in interfere viral replication, 
80Iecuiar competitive pattern of antibody - receptor to antigen complex bind was important 
ilformation. 
AiJns: Here wedetermined I) binding affinity of complex glycoprotein molecule (antigen) 
_ a receptor molecule to affinity of complex glycoprotein molecule (antigen) and 
_bodies molecule using surface plasmon resonance (SPR);2) competitive of molecular 
fIIltern interaction in several time exposure series using western blot assay (WBA). 
lIrthods :Both quantitative and qualitative studies were done in this study. Complex 
Jiycoprotein molecule were defined into Fc and non Fc contained, and also protein of 
IIlI:eptor and antibodies, both defined into Fc and non Fc. 
TlDle exposure series of competitive assay were divide into immediate, intermediate and late 
asponse.WBA was used to detect antibody to complex glycoprotein molecule (antigen) 
&esult :Using SPR, we defined the concentration of binding ability at low concentration of 
iIs complex. High potential antibodies in interfere viral replication mostly got higher binding 
dinity to antigen than its receptor to antigen. Similar concentration of binding affinity of 
-.ligen-antibody complex to antigen-receptor complex binding effected the molecular 
iateraction after several hours incubation. 
Table 1 SPR : Complex glycoprotein (Antigen) to protein A in resonance chip 
Analyte kon (llM.s) Koff (lis) KD (nM) 
Receptor 1,1 x 1if 1,6 X 10-2 14 
Antibody A 3,5 X lO" 6,6 X 10-4 19 
Antibody B 8,5 X lO" 3,9 X 10-4 46 
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